Search
for
Sort by
Research 841–870 of 1000+
- Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line
- On the Horizon From the ORS
- Allopregnanolone Alters the Gene Expression Profile of Human Glioblastoma Cells
- Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
- Para rubber seed oil: The safe and efficient bio‐material for hair loss treatment
- Bioactives in Chinese Proprietary Medicine Modulates 5α-Reductase Activity and Gene Expression Associated with Androgenetic Alopecia
- Treatment options for alopecia areata
- Antioxidant activity of various solvent extracts from endophytic bacteria isolated from girang (Leea indica) leaves
- Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
- Effect of the multifunctional cosmetic ingredient sphinganine on hair loss in men and women with diffuse hair reduction
- Synergistic effect of sorafenib with Platycladus orientalis (L) leaf extract on cervical cancer
- Derivation of Stem Cell-like Cells From Spherical Culture of Astrocytes for Enhanced Neural Repair After Middle Cerebral Artery Occlusion
- Extracellular Vesicles for Androgenetic Alopecia: Current Evidence, Mechanisms, and Clinical Prospects
- Composition, structural features, and multifunctional properties of extracellular polysaccharides from the non-toxic green alga Parachlorella sp.
- (7E)-7,8-Dehydroheliobuphthalmin from Platycladus orientalis L.: Isolation, Characterization, and Hair Growth Promotion
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Unrevealing the Potential of Sansevieria trifasciata Prain Fraction for the Treatment of Androgenetic Alopecia by Inhibiting Androgen Receptors Based on LC-MS/MS Analysis, and In-Silico Studies
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies
- Intracavernous injection of platelet‐rich plasma reverses erectile dysfunction of chronic cavernous nerve degeneration through reduction of prostate hyperplasia evidence from an aging‐induced erectile dysfunction rat model
- Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation
- Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway
- Development and validation of an UPLC method for determination of content uniformity in low-dose solid drugs products using the design space approach
- Pharmacological Effects of the Lipidosterolic Extract from Kigelia africana Fruits in Experimental Benign Prostatic Hyperplasia Induced by Testosterone in Sprague Dawley Rats
- Lichen Planopilaris Responsive to a Novel Phytoactive Botanical Treatment: A Case Series